Resource management in cardiovascular engineering: is outsourcing the solution?

Feyrer, Richard; Weyand, Michael; Kunzmann, Udo
September 2005
Perfusion;Sep2005, Vol. 20 Issue 5, p289
Academic Journal
In recent years, modern medicine has changed considerably. At maximum care centers, in particular, the use of state-of-the-art medical equipment has become an essential part of patient care. However, using such high-tech products also means a considerable burden on the financial resources available, because additional financing is rare. Consequently, there is a need for approaches that allow the use of state-of-the-art equipment without straining the budget unduly. The question now is whether economic strategies that have long since been established in other industries, e.g., the outsourcing of certain services, represent a potential solution for the economic problems of modern clinics. The fundamentals of outsourcing and its pros and cons are outlined and discussed, taking cardiovascular perfusion as an example, a cost-intensive field of heart surgery that is responsible for attending to heart–lung machines, artificial hearts and circulatory support systems.


Related Articles

  • After PAS-Port OK by FDA, Cardica's shares jump by 35%. FORD, OMAR // Cardiovascular Devices & Drugs;Oct2008, Vol. 14 Issue 10, p22 

    The article reports on the approval of the PAS-Port Proximal Anastomosis System from Cardica by the U.S. Food and Drug Administration (FDA). The system is for use in cardiac bypass surgery in the U.S. The FDA approval resulted in more than 35 percent rise in the stock price of the company. It is...

  • Algorithm developed to predict need for RV support post-LVAD. Young, James B. // Cardiology Today;Jun2008, Vol. 11 Issue 6, p14 

    The article focuses on the data reviewed by J.R. Fitzpatrick III, MD, general surgery resident, division of cardiac surgery at the Hospital of the University of Pennsylvania and his colleagues related to determination of preoperative risks factors for a need for an RV assist device (RVAD) after...

  • Heart Support. Stone, Andy // Forbes Asia;5/5/2008, Vol. 4 Issue 8, p68 

    The article focuses on the clinical trial of HeartMate II, a heart pump from Thoratec Corp. The company is awaiting U.S. Food & Drug Administration clearance for its use as a stopgap for patients hoping to get a heart. In 2009 the trial will be completed, which aimed at showing that the device...

  • Corevalve trial seeks to move TAVI to lower-risk patients. Brosky, John // Medical Device Daily;7/19/2012, Vol. 16 Issue 139, p2 

    The article reports on Medtronic's Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial. The first of 2,500 patients had been enrolled in a multi-center, randomized clinical trial. The trial will compare the percutaneous placement of the company's Corevalve aortic...

  • Left atrial appendage perforation during interventional occluder implantation. Peterss, Sven; Hagl, Christian; Shrestha, Malakh; Khaladj, Nawid // European Journal of Cardio-Thoracic Surgery;Apr2012, Vol. 41 Issue 4, p961 

    The article focuses on perforation of left atrial appendage during interventional occluder implantation and also includes several images showing intraoperative view.

  • Shelhigh to meet FDA standards for devices.  // Medical Technology & Devices Week;7/2/2007, Vol. 5 Issue 27, p3 

    The article reports on the decision of Shelhigh to stop distributing its implantable medical devices used in heart surgery and other procedures until it brings its production processes in line with the standards of the U.S. Food and Drug Administration. According to the medical device...

  • Applied Physics Letters: A millimeter-scale, wirelessly powered cardiac device.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article informs that the scale of medical devices implanted in the human body can be altered with the help of a millimeter-sized wireless powered cardiac device.

  • German patient completes one year on BestBeat pump.  // Medical Device Daily;3/21/2008, Vol. 12 Issue 56, p1 

    The article focuses on a report by medical equipment maker NewCorTec that a German patient is the first to log 365 days of support on the Best-Beat ventricular-assist device, a new heart-assist device designed to provide cardiac support for patients with end-stage heart-failure. The patient was...

  • Controlling Implant Costs.  // hfm (Healthcare Financial Management);Apr2006, Vol. 60 Issue 4, Special section p1 

    The article introduces a panel discussion regarding the challenges of controlling implant costs and partnering effectively with physicians and vendors. The article explains the correlation between innovations in cardiac and orthopedic implants and high costs. According to the article, the device...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics